Requires an insurer to cap the total amount an insured is required to pay for a 30 day supply of prescription insulin drugs at an amount not to exceed $35, regardless of the number of prescriptions and different types of insulin prescribed and filled during that period.
- Chamber
- Senate
- Introduced
- Jan 5, 2026
- Last action
- Jan 5, 2026 — First reading: referred to Committee on Health and Provider Services
- Session
- 2026
- Momentum
- 27 · Low